Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention

Vaccine

Volumn 25, Issue 35, 2007, Pages 6437-6446

  Esposito, Susanna ^a   Bosis, Samantha ^a   Pelucchi, Claudio ^b   Begliatti, Enrica ^a   Rognoni, Alessandro ^a   Bellasio, Marta ^a   Tel, Francesca ^a   Consolo, Silvia ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

HPV; Pediatrics; Prevention; Sexually transmitted diseases; Vaccines

Indexed keywords

VIRUS VACCINE;

ADOLESCENCE; ADULT; ARTICLE; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HOSPITAL PHYSICIAN; HUMAN; ITALY; MALE; MEDICAL INFORMATION; MEDICAL PRACTICE; NORMAL HUMAN; PARENT; PEDIATRICIAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ITALY; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PEDIATRICS; PHYSICIANS; QUESTIONNAIRES; RELIGION; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS;

EID: 34547645251     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.053     Document Type: Article

References (39)

1. Trottier H., and Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 24 Suppl. 1 (2006) S1-S15
2. Parkin D.M., and Bray F. The burden of HPV-related cancers. Vaccine 24 Suppl. 3 (2006) S11-S25
3. Burchell A.N., Winer R.L., de Sanjose S., and Franco E.L. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 24 Suppl. 3 (2006) S52-S61
4. Sinclair K.A., Woods C.R., Kirse D.J., and Sinal S.H. Anogenital and respiratory tract human papillomavirus infections among children: age, gender, and potential transmission through sexual abuse. Pediatrics 116 (2005) 815-825
5. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
6. Woodman C.B., Collins S., Winter H., Bailey A., Ellis J., Prior P., et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357 (2001) 1831-1836
7. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
8. Ronco G., Ghisetti V., Segnan N., Snijders P.J., Gillio-Tos A., Meiier C.J., et al. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 41 (2005) 297-305
9. Greer C.E., Wheeler C.M., Ladner M.B., Beutner K., Coyne M.Y., Liang H., et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 33 (1995) 2058-2063
10. Munoz N., Castellsague X., de Gonzalez A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Suppl. 3 (2006) S1-S10
11. Clifford G., Franceschi F., Diaz M., Munoz N., and Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine Suppl. 3 (2006) S26-S34
12. Harper D.M., Franco E.L., Wheeler C.M., Ferris D.G., Jenkis D., Schuind A., et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364 (2004) 1757-1765
13. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., et al. Prophylactic quadrivalent human papillomavirus (types 6 11 16 and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6 (2005) 271-278
14. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 45 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 (2006) 1247-1255
15. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Paavonen J., Iversen O.E., et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 95 (2006) 1459-1466
16. Franco E.L., and Harper D.M. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 23 (2005) 2388-2394
17. Frazer I.H., Cox J.T., Mayeaux Jr. E.J., Franco E.L., Moscicki A.B., Palefsky J.M., et al. Advances in prevention of cervical cancer and other human papillomavirus-related diseases. Pediatr Infect Dis J 25 Suppl. 2 (2006) S65-S81
18. Stanley M.A. Human papillomavirus vaccines. Rev Med Virol 16 (2006) 139-149
19. Kadish A.S., and Einstein M.H. Vaccine strategies for human papillomavirus-associated cancers. Curr Opin Oncol 17 (2005) 456-461
20. Department of Health and Human Services, Centers for Disease Control and Prevention. Vaccines for Children Program (VFC) CDC National Immunization Program, 2006. Available at: www.cdc.gov. Accessed October 30, 2006.
21. Saslow D., Castle P.E., Cox J.T., Davey D.D., Einstein M.H., Ferris D.G., et al. American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 57 (2007) 7-28
22. Dempsey A.F., Zimet G.D., Davis R.L., and Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 117 (2006) 1486-1493
23. Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav 2007. [Jan 3 epub].
24. Clark L.R., Jackson M., and Allen-Taylor L. Adolescent knowledge about sexually transmitted diseases. Sex Transm Dis 29 (2002) 436-443
25. Olshen E., Woods E.R., Austin S.B., Luskin M., and Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 37 (2005) 248-251
26. Baay M.F.D., Verhoeven V., Peremans L., Avonts D., and Vermorken J.B. General practitioners' perception of risk factors for cervical cancer development: consequences for patient education. Patient Educ Couns 62 (2006) 277-281
27. Brabin L., Roberts S.A., Farzaneh F., and Kitchener H.C. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 24 (2006) 3087-3094
28. Daley M.F., Liddon N., Crane L.A., Beaty B.L., Barrow J., Babbel C., et al. A national survey of paediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 118 (2006) 2280-2289
29. Kahn J.A., and Bernstein D.I. Human papillomavirus vaccines and adolescents. Curr Opin Obstetr Gynecol 17 (2005) 476-482
30. Villa L.L. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases. Vaccine 24 Suppl. 1 (2006) S23-S28
31. Zimet G.D., Mays R.M., Sturm L.A., Bair R.M., Juliar B.E., and Mays R.M. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 159 (2005) 132-137
32. Esposito S., Marchisio P., Droghetti R., Lambertini L., Faelli N., Bosis S., et al. Influenza vaccination coverage among children with high-risk medical conditions. Vaccine 24 (2006) 5251-5255
33. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 37 (2005) 502-510
34. Raley J.C., Followwill K.A., Zimet G.D., and Adult K.A. Gynecologists' attitudes regarding human papillomavirus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 12 (2004) 127-133
35. Mays R.M., and Zimet G.D. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sex Transm Dis 31 (2004) 428-432
36. Castellino N., Bellone S., Rapa A., Vercellotti A., Bigotti M., Petri A., et al. Puberty onset in Northern Italy: a random sample of 3597 Italian children. J Endocrinol Invest 28 (2005) 589-594
37. Buhi E.R., and Goodson P. Predictors of adolescent sexual behaviour and intention: a theory-guided systematic review. J Adolesc Health 40 (2007) 4-21
38. Kirby D. The impact of schools and school programs upon adolescent sexual behaviour. J Sex Res 39 (2002) 27-33
39. Cohen D.A., Farley T.A., Taylor S.N., Martin D.H., and Schuster M.A. When and where do youths have sex? The potential role of adult supervision. Pediatrics 110 (2002) e66